Effects of Variations in Caffeinated Beverages on Well-being

This will evaluate post-beverage subjective caffeine responses using visual analog scale questionnaires, mood, quality of life, and physiological responses to ingredient variations in caffeine beverages.

Inclusion criteria

• Males or females, ≥18 to ≤55 years of age
• BMI ≥18.5 and <35.0 kg/m2
• Generally good health
• Participant currently and consistently has a sweetened caffeine routine
• Participant is willing to substitute their current caffeine routine for the test beverage daily
• Participant has never consumed the test beverage or similar products
• Participant currently owns a wearable and is willing to use and connect the wearable device
• Willing to use personal smart phone, tablet, or personal computer with stable internet connection
• Willing and able to comply with all study procedures
• Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study

Exclusion criteria

• History or presence, on the basis of the health history, of clinically important condition or disease states
• Is currently following, or planning to be on, a weight loss regimen
• Weight loss or gain >4.5 kg
• History of gastrointestinal surgery for weight reducing purposes or gastrointestinal (GI) conditions
• History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator.
• History of unconventional sleep patterns (e.g., night shift) or diagnosed sleep disorder
• Use of tobacco/nicotine products
• Use of hemp/marijuana products
• Unstable use of any prescription medication
• Use of any medications(s) or dietary supplement(s), containing caffeine, or interacting with caffeine
• Recent history of alcohol or substance abuse
• Exposed to any non-registered drug product
• Self-report of hypertension/high blood pressure without use of hypertensive medications
• Any known allergy or intolerance to any ingredients contained in the study product
• Any signs or symptoms of active infection of clinical relevance
• History or presence of cancer, except for non-melanoma skin cancer
• History of any major trauma or major surgical event
• Female who is pregnant, planning to be pregnant during the study period, lactating
• An employee, close relative of an employee, or participant who has a financial interest in Sponsor company or any other caffeine beverage company.
• Any condition the Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol
• A clinically significant medical condition that is affected by caffeine